Stability of 18F-Deoxyglucose Uptake Locations Within Tumor During Radiotherapy for NSCLC: A Prospective Study

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 5, 2008, Pages 1402-1407

  Aerts, Hugo J W L ^a   Bosmans, Geert ^a   van Baardwijk, Angela A W ^a   Dekker, Andre L A J ^a   Oellers, Michel C ^a   Lambin, Philippe ^a   De Ruysscher, Dirk ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adaptive radiotherapy; FDG uptake; Non small cell lung cancer; Positron emission tomography computed tomography; Tumor heterogeneity

Indexed keywords

ADAPTIVE RADIOTHERAPY; FDG UPTAKE; NON-SMALL-CELL LUNG CANCER; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; TUMOR HETEROGENEITY;

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG STABILITY; DRUG TRANSPORT; DRUG UPTAKE; FEMALE; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TUMOR VOLUME; LUNG TUMOR; METABOLISM; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; SCINTISCANNING;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 47149110193     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.11.049     Document Type: Article

References (34)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
2. Curran W.J., Scott C.B., and Langer C.J. Long-term benefit is observed in a phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III NSCLC. [Abstract]. Proc Am Soc Clinic Oncol A 22 (2003) 621
3. Fournel P., Robinet G., Thomas P., et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 study. J Clin Oncol 23 (2005) 5910-5917
4. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
5. Zatloukal P., Petruzelka L., Zemanova M., et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: A randomized study. Lung Cancer 46 (2004) 87-98
6. Bradley J. A review of radiation dose escalation trials for non-small cell lung cancer within the Radiation Therapy Oncology Group. Semin Oncol 32 (2005) S111-S113
7. Cooper R.A., Carrington B.M., Loncaster J.A., et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol 57 (2000) 53-59
8. Foo S.S., Abbott D.F., Lawrentschuk N., et al. Functional imaging of intratumoral hypoxia. Mol Imaging Biol 6 (2004) 291-305
9. Garcia-Segura J.M., Sanchez-Chapado M., Ibarburen C., et al. In vivo proton magnetic resonance spectroscopy of diseased prostate: Spectroscopic features of malignant versus benign pathology. Magn Reson Imaging 17 (1999) 755-765
10. Piert M., Machulla H.J., Picchio M., et al. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. J Nucl Med 46 (2005) 106-113
11. 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med 46 (2005) 675-682
12. Bentzen S.M. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
13. Das S.K., Miften M.M., Zhou S., et al. Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions. Med Phys 31 (2004) 1452-1461
14. Dubois L., Landuyt W., Haustermans K., et al. Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry. Br J Cancer 91 (2004) 1947-1954
15. van Baardwijk A., Bosmans G., Dekker A., et al. Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy: A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients. Radiother Oncol 82 (2007) 145-152
16. Borst G.R., Belderbos J.S., Boellaard R., et al. Standardised FDG uptake: A prognostic factor for inoperable non-small cell lung cancer. Eur J Cancer 41 (2005) 1533-1541
17. Downey R.J., Akhurst T., Gonen M., et al. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection. J Clin Oncol 22 (2004) 3255-3260
18. Eschmann S.M., Friedel G., Paulsen F., et al. Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?. Eur J Nucl Med Mol Imaging 33 (2006) 263-269
19. van Baardwijk A., Dooms C., van Suylen R.J., et al. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. Eur J Cancer 43 (2007) 1392-1398
20. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., et al. for the Leuven Lung Cancer Group. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: An analysis of 125 cases. J Clin Oncol 17 (1999) 3201-3206
21. De Ruysscher D., Wanders R., van Haren E., et al. HI-CHART: A phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small cell lung cancer. Int J Radiat Oncol Biol (2007) in press [Epub ahead of print]
22. Daisne J.F., Duprez T., Weynand B., et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 233 (2004) 93-100
23. Senan S., De Ruysscher D., Giraud P., et al. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 71 (2004) 139-146
24. van Baardwijk A., Bosmans G., Boersma L., et al. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. Int J Radiat Oncol Biol Phys 68 (2007) 771-778
25. Apisarnthanarax S., and Chao K.S. Current imaging paradigms in radiation oncology. Radiat Res 163 (2005) 1-25
26. Bentzen S.M. Radiation therapy: intensity modulated, image guided, biologically optimized and evidence based. Radiother Oncol 77 (2005) 227-230
27. Ling C.C., Humm J., Larson S., et al. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality. Int J Radiat Oncol Biol Phys 47 (2000) 551-560
28. Bosmans G., van Baardwijk A., Dekker A., et al. Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: A prospective clinical study. Int J Radiat Oncol Biol Phys 66 (2006) 748-753
29. Alber M., Paulsen F., Eschmann S.M., et al. On biologically conformal boost dose optimization. Phys Med Biol 48 (2003) N31-N35
30. Chao K.S., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
31. De Meerleer G., Villeirs G., Bral S., et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: Planning and delivery of intensity-modulated radiotherapy. Radiother Oncol 75 (2005) 325-333
32. DiBiase S.J., Hosseinzadeh K., Gullapalli R.P., et al. Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 429-438
33. Xing L., Cotrutz C., Hunjan S., et al. Inverse planning for functional image-guided intensity-modulated radiation therapy. Phys Med Biol 47 (2002) 3567-3578
34. Daisne J.F., Sibomana M., Bol A., et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: Influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250